Neprilysin 4, a novel endopeptidase from Drosophila melanogaster, displays distinct substrate specificities and exceptional solubility states

Autor(en): Meyer, Heiko
Panz, Mareike
Zmojdzian, Monika
Jagla, Krzysztof
Paululat, Achim 
Stichwörter: Biology; BRAIN; CELL FATES; DEFICIENT; FERTILITY; glia cells; HEART; IDENTIFICATION; INACTIVATION; Life Sciences & Biomedicine - Other Topics; metalloendopeptidase; muscle founders; NEP; NEUTRAL ENDOPEPTIDASE; peptide metabolism; pericardial cells; ZINC-METALLOPEPTIDASE
Erscheinungsdatum: 2009
Herausgeber: COMPANY BIOLOGISTS LTD
Journal: JOURNAL OF EXPERIMENTAL BIOLOGY
Volumen: 212
Ausgabe: 22
Startseite: 3673
Seitenende: 3683
Zusammenfassung: 
Proteins belonging to the family of neprilysins are typically membrane bound M13 endopeptidases responsible for the inactivation and/or activation of peptide signaling events on cell surfaces. Mammalian neprilysins are known to be involved in the metabolism of various regulatory peptides especially in the nervous, immune, cardiovascular and inflammatory systems. Although there is still much to learn about their participation in various diseases, they are potential therapeutic targets. Here we report on the identification and first characterization of neprilysin 4 (NEP4) from Drosophila melanogaster. Reporter lines as well as in situ hybridization combined with immunolocalization demonstrated NEP4 expression during embryogenesis in pericardial cells, muscle founder cells, glia cells and male gonads. Western blot analysis confirmed the prediction of one membrane bound and one soluble isoform, a finding quite unusual among neprilysins with presumably strong physiological relevance. At least one NEP4 isoform was found in every developmental stage indicating protein activities required throughout the whole life cycle of Drosophila. Heterologously expressed NEP4 exhibited substrate preferences comparable to human neprilysin 2 with distinct cleavage of substance P and angiotensin I.
ISSN: 00220949
DOI: 10.1242/jeb.034272

Show full item record

Page view(s)

4
Last Week
0
Last month
0
checked on Apr 23, 2024

Google ScholarTM

Check

Altmetric